tm
Seeing Is Believing
tm
Seeing Is Believing
CATX is currently covered by 5 analysts with an average price target of $11.39. This is a potential upside of $7.33 (180.54%) from yesterday's end of day stock price of $4.06.
Perspective Therapeutics's activity chart (see below) currently has 2 price targets and 17 ratings on display. The stock rating distribution of CATX is 93.75% BUY and 6.25% HOLD.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 53.33 days.
Highest price target for CATX is $16, Lowest price target is $6, average price target is $11.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 23-Jun-2025. First documented stock forecast 14-Jun-2024.
Currently out of the existing stock ratings of CATX, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$6.8 (161.90%)
$20
1 months 2 days ago
(23-Jun-2025)
0/3 (0%)
$6.89 (167.64%)
Buy
$16
$11.8 (280.95%)
$16
6 months 11 days ago
(14-Jan-2025)
1/4 (25%)
$12.8 (400.00%)
160
Hold
$6
$1.8 (42.86%)
$24
8 months ago
(25-Nov-2024)
0/2 (0%)
$2.31 (62.60%)
What is CATX (Perspective Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CATX (Perspective Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CATX (Perspective Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CATX (Perspective Therapeutics)?
Which analyst is the currently most bullish on CATX (Perspective Therapeutics)?
Which analyst is the currently most reserved on CATX (Perspective Therapeutics)?
